4.8000
-1.3000
(-21.31%)
At close: January 10 at 9:07:09 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-166,184.0000
-192,231.0000
-5,853.0000
-124,982.0000
-67,881.0000
Investing Cash Flow
31,468.0000
68,355.0000
-225,644.0000
15,461.0000
58,289.0000
Financing Cash Flow
2,370.0000
115,068.0000
219,382.0000
2,476.0000
214,781.0000
End Cash Position
43,065.0000
113,112.0000
121,920.0000
134,035.0000
241,080.0000
Income Tax Paid Supplemental Data
--
625.0000
--
--
--
Capital Expenditure
-6,438.0000
-12,381.0000
-10,206.0000
-13,244.0000
-17,502.0000
Issuance of Capital Stock
--
113,564.0000
217,987.0000
--
215,691.0000
Free Cash Flow
-172,622.0000
-204,612.0000
-16,059.0000
-138,226.0000
-85,383.0000
12/31/2020 - 9/18/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LSRM.MU CEL-SCI Corp
0.3628
-0.38%
LSRM.SG CEL-SCI Corp
0.3992
+13.67%
LSRM.F CEL-SCI Corporation
0.3478
-0.11%
LSRM.BE CEL-SCI Corp
0.3470
+0.17%
LSRM.DU CEL-SCI Corp
0.3846
+9.57%
NFX.L Nuformix plc
0.0600
+26.32%
OBD.L Oxford BioDynamics Plc
0.9110
-8.90%
ATNFW 180 Life Sciences Corp.
0.0100
-4.76%
TCBPW TC Biopharm (Holdings) Plc
0.0150
+19.05%
IPH.PA Innate Pharma S.A.
1.8080
+2.15%